Aurobindo Pharma Ltd’s consolidated net profit increased 33 per cent at Rs 605.64 crore in the second quarter ended September 30, 2016 compared to Rs 453.55 crore in the corresponding quarter of previous financial year.
The total revenue of the Hyderabad-based company has increased 12% at Rs 3775 cr as against Rs 3365 crore.
The board of the company has approved an interim divided of 125 per cent per equity share of Rs 1 for the year 2016-17.